Sign in
BLACU Stock Price, Chart, Stats & News
Bellevue Life Sciences Acquisition Corp.
Save
6.98M
Market cap
–
Current P/E
–
Forward P/E
BLACU chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 18.35% |
Operating margin | -473.37% |
Pretax margin | -836.11% |
Net margin | -784.81% |
Effective tax rate | 6.13% |
ROA | -11.18% |
ROE | -19.86% |
D/E | 0.00x |
Interest coverage ratio | -122.95x |
BLACU valuation
P/E | – |
P/S | 2.77x |
P/B | 0.11x |
P/CF | -4.62x |
P/FCF | -2.14x |
P/OCF | -4.62x |
PEG | 0.08x |
EV multiple | -1.12x |
About
Bellevue Life Sciences Acquisition Corp. currently lacks substantial active operations. Its principal aim is to pursue and finalize a strategic business combination—such as a merger, share swap, asset purchase, stock acquisition, financial restructuring, or corporate reorganization—with one or more businesses or organizations within the healthcare sector. Established in 2020, the firm maintains its main office in Bellevue, Washington, and functions as a subsidiary of Bellevue Global Life Sciences Investors LLC.
Similar securities
Based on sector and market capitalization
Report issue